{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-021841","form_type":"8-K","ticker":null,"cik":"0001865127","company_name":"Lucy Scientific Discovery, Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.141063+00:00","generated_at":"2026-06-04T23:26:34.252712+00:00","sec_items":["1.02"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lucy Scientific terminates Bluesky Biologicals amalgamation agreement due to missing audited financials","bullets":["Terminated Amalgamation Agreement with Bluesky Biologicals on March 5, 2024, per Article 6.1.","Reason: Bluesky failed to timely provide audited financial statements, as required under the agreement.","Original agreement dated September 12, 2023, for a three-cornered amalgamation involving Lucy issuing securities.","Either party could terminate if conditions not met by December 31, 2023; Lucy exercised that right."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-021841","json":"https://secwatch.observer/filing/0001213900-24-021841.json","markdown":"https://secwatch.observer/filing/0001213900-24-021841.md","text":"https://secwatch.observer/filing/0001213900-24-021841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024021841/0001213900-24-021841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024021841/ea0201661-8k_lucy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:26:34.252712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8decd688f2e4632a301206cb0579b4a242eef618","claim":"Lucy Scientific Discovery, Inc. terminated Amalgamation Agreement with Bluesky Biologicals Inc. (effective 2024-03-05).","evidence_excerpt":"nd Bluesky Biologicals Inc., a corporation existing under the laws of the Province of British Columbia (“ Bluesky ” or “ Acquiree ”), entered into that certain Amalgamation Agreement (the “ Agreement ”), pursuant to","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865127/000121390024021841/0001213900-24-021841-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Bluesky Biologicals Inc."},{"label":"Effective","value":"2024-03-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}